Literature DB >> 17090619

Activation-induced endocytosis of the raft-associated transmembrane adaptor protein LAB/NTAL in B lymphocytes: evidence for a role in internalization of the B cell receptor.

Cathlin M Mutch1, Ratna Sanyal, Tammy L Unruh, Lana Grigoriou, Minghua Zhu, Weiguo Zhang, Julie P Deans.   

Abstract

Linker for activation of B cell (LAB)/non-T cell activation linker (NTAL) and phosphoprotein associated with glycophospholipid-enriched membrane microdomain (PAG)/Csk-binding protein (Cbp) are raft-associated transmembrane adaptor proteins with distinct functions in immediate/early phases of receptor signaling pathways. Heterogeneous rafts are thought to compartmentalize membrane-associated signaling events. In order to investigate the subcellular localization of LAB/NTAL and PAG/Cbp, they were expressed as fluorescent chimeric fusion proteins in a human B cell line and their distribution was examined, along with the corresponding endogenous proteins, before and after B cell receptor (BCR) stimulation. Both adaptors were distributed predominantly at the plasma membrane in resting cells and co-clustered with other raft-associated proteins; however, they distributed differently in buoyant membranes isolated by either detergent resistance or non-detergent methods, indicating that they might localize to distinct rafts. After activation, LAB/NTAL was internalized and co-localized with the BCR while PAG/Cbp remained on the cell surface. BCR internalization was reduced in LAB/NTAL-deficient murine B cells, suggesting a regulatory role for LAB/NTAL in activation-induced internalization of the BCR. The cytoplasmic domain of LAB/NTAL, and not the transmembrane/juxtamembrane region, was found to be essential for its internalization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090619     DOI: 10.1093/intimm/dxl118

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

Review 1.  LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?

Authors:  Selinda J Orr; Daniel W McVicar
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

2.  Protein sorting by lipid phase-like domains supports emergent signaling function in B lymphocyte plasma membranes.

Authors:  Matthew B Stone; Sarah A Shelby; Marcos F Núñez; Kathleen Wisser; Sarah L Veatch
Journal:  Elife       Date:  2017-02-01       Impact factor: 8.140

3.  Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments.

Authors:  Akanksha Chaturvedi; Rebecca Martz; David Dorward; Michael Waisberg; Susan K Pierce
Journal:  Nat Immunol       Date:  2011-10-02       Impact factor: 25.606

4.  Palmitoylation-dependent plasma membrane transport but lipid raft-independent signaling by linker for activation of T cells.

Authors:  Matthias Hundt; Yohsuke Harada; Lauren De Giorgio; Natsuko Tanimura; Weiguo Zhang; Amnon Altman
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

Review 5.  Lipid rafts and B cell signaling.

Authors:  Neetu Gupta; Anthony L DeFranco
Journal:  Semin Cell Dev Biol       Date:  2007-07-24       Impact factor: 7.727

Review 6.  Endocytic events in TCR signaling: focus on adapters in microclusters.

Authors:  Lakshmi Balagopalan; Valarie A Barr; Lawrence E Samelson
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

7.  Vav and Rac activation in B cell antigen receptor endocytosis involves Vav recruitment to the adapter protein LAB.

Authors:  Shikha Malhotra; Susan Kovats; Weiguo Zhang; K Mark Coggeshall
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

8.  B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin.

Authors:  Shikha Malhotra; Susan Kovats; Weiguo Zhang; K Mark Coggeshall
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

9.  Synthetic antigens reveal dynamics of BCR endocytosis during inhibitory signaling.

Authors:  Adam H Courtney; Nitasha R Bennett; Daniel B Zwick; Jonathan Hudon; Laura L Kiessling
Journal:  ACS Chem Biol       Date:  2013-11-14       Impact factor: 5.100

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.